COVID vaccine
University of Hong Kong, Sinopharm launch trial of Omicron-targeting vaccine
University of Hong Kong, Sinopharm launch trial of Omicron-targeting vaccine
A total of 1,800 adult volunteers will be needed for the trial.
Read Here
Advertise
Sign Up
Commentary
Navigating Hong Kong’s regulatory landscape: a challenging and rewarding endeavour
Wellness craze: Emerging growth for commercial space